NEXTBio Capital Management LP

Q3 2026 13F-HR Holdings

Location
Austin, TX
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
25
Total value ($000)
$234,373
Net value change ($000)
+16,976 (7.8%)
New positions
5
Sold out positions
2
Turnover %
11.1%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ENTXW 8,509 NEW
PHVS 8,080 216.2%
KORSANA BIOSCIENCES INC 5,613 NEW
BLOSSOMHILL THERAPEUTICS INC 4,660 NEW
PTGX 4,016 14.9%
ZLAB 2,794 80.2%
VSTM 2,307 46.2%
ADARX PHARMACEUTICALS INC 1,994 NEW
ORIC 1,573 20.6%
GLUE 1,330 NEW
Top Reduces (Value $000, Stocks/ETFs)
GPCR -7,000 -41.7%
VOR -4,523 -27.6%
CMPS -3,037 -12.1%
PVLA -2,649 -19.3%
BIOA -2,469 -100.0%
RYTM -2,084 -14.2%
ACET -1,364 -100.0%
CBIO -1,271 -18.9%
EVMN -599 -37.9%
STTK -447 -1.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type